News
12h
Zacks Investment Research on MSNWill United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on United Therapeutics (UTHR – Research ...
Liquidia's collaboration with Sandoz and development of new products like L606 show promise. Learn why LQDA stock is a Hold.
StockStory.org on MSN1d
Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Denali Therapeutics is advancing the fight against neurodegenerative diseases thanks to pioneering work in methods to address ...
Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.
“The past year has been transformational for Tenax Therapeutics in our quest to ... although it is not available in the United States or Canada. Tenax’s Phase 2 HELP study, including its ...
Those following along with Cartesian Therapeutics, Inc. (NASDAQ:RNAC) will no doubt be intrigued by the recent purchase of shares by Timothy Springer, Director of the company, who spent a stonking ...
Plus Therapeutics shares are trading higher by 244% during Thursday's session. The company announced that the FDA accepted the name REYOBIQ for the company's lead asset. The ‘Trade of the Day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results